查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498776

尿路感染治疗市场，按疾病、药物类别、配销通路、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Urinary Tract Infection Treatment Market, By Disease, By Drug Class, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年泌尿道感染治疗市场规模为92.3821亿美元，2024年至2032年复合年增长率为3.98%。

尿路感染治疗市场-市场动态

尿路感染的日益普及和先进的诊断技术预计将推动市场需求

泌尿道感染（UTI）盛行率不断上升，推动了对有效治疗替代方案的需求，这种感染在女性、老年人和慢性病患者中尤其常见，预计将推动市场成长。作为最常见的细菌感染之一，泌尿道感染需要可靠且定期的治疗替代方案。较高的诊断率是对泌尿道感染症状的了解增加以及及时治疗的重要性的结果。改进的诊断仪器和公共卫生措施支持早期检测和治疗，从而加速市场扩张。

分子诊断和快速尿液检测等诊断技术的技术发展提高了诊断泌尿道感染的准确性和速度。这改善了治疗效果并推动了用于诊断和治疗的医疗设备市场。增加医疗保健支出使获得医疗设施和泌尿道感染治疗变得更加容易，尤其是在发展中国家。由于这些经济因素，尿路感染治疗市场正在不断成长。此外，政府活动和医疗保健组织对更好的泌尿道感染管理的支持也对市场产生了积极影响。这些措施包括为研究和发展、公共卫生运动和加强医疗基础设施提供资金。

尿路感染治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 3.98% 左右的复合年增长率成长

根据疾病细分，由于泌尿系统疾病的盛行率不断上升，预计复杂尿路感染细分市场将在 2023 年显示最大的市场份额。

根据药物类别细分，由于对肾臟相关疾病治疗的高需求，喹诺酮类药物细分市场将在 2023 年成为领先的药物类别。

根据配销通路细分，由于对肾臟和糖尿病疾病治疗的高需求，医院药房细分市场将在 2023 年成为领先的配销通路。

按地区划分，由于公司医疗保健支出不断增长，北美将成为 2023 年的主要收入来源。

尿路感染治疗市场-細項分析：

全球尿路感染治疗市场根据疾病、药物类别、配销通路和地区进行细分。

市场依疾病分为两类：复杂性泌尿道感染及简单性泌尿道感染。复杂的尿路感染细分市场占据主导地位。疾病治疗的进步和新设备的采用正在推动该领域的成长。

依药物类别，市场分为五类：喹诺酮类、β-内酰胺类、大环内酯类、氨基糖苷类等。喹诺酮类药物在市场上占据主导地位。由于人们对泌尿道感染的了解不断增加，寻求医疗照护的需求不断增长，这推动了市场的成长。

根据分销管道，市场分为三类：零售药局、网路药局和医院药局。医院药房领域在市场中占据主导地位，预计在预测期内将保持其较高的主导地位。随着电子商务行业的兴起加速了市场的成长，线上药局预计将以最快的复合年增长率成长。

泌尿道感染治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美正在主导全球市场。该地区拥有先进的医疗基础设施，可以轻鬆获得诊断和治疗。由于高额医疗支出和强劲的製药业，北美拥有最大的市场份额。预计亚太地区在预测期内将以最高的速度扩张。

尿路感染治疗市场-竞争格局：

泌尿道感染 (UTI) 治疗市场竞争激烈，由多家参与 UTI 管理药物和疗法开发、製造和分销的关键参与者组成。公司正致力于开发下一代抗生素和针对多重抗药性感染的治疗方法。例如，葛兰素史克公司参与了解决抗菌素抗药性的合作努力，并拥有多种化合物正在进行细菌感染的临床试验。

最近的发展：

2022年，Spero Therapeutics Inc.向美国食品药物管理局（FDA）提交了新药申请（NDA），并获得批准用于治疗复杂性尿路感染（cUTI）的氢溴酸替比培南片剂。

2022 年，印度领先的仿製药公司 BDR Pharma 推出了比阿培南，用于治疗腹内感染和复杂泌尿道感染患者。

目录

第一章：尿路感染治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 依疾病分类的泌尿道感染治疗市场片段
    • 按药物类别分類的泌尿道感染治疗市场片段
    • 按配销通路分類的尿路感染治疗市场片段
    • 按国家/地区分類的泌尿道感染治疗市场片段
    • 按地区分類的泌尿道感染治疗市场片段
  • 竞争洞察

第 3 章：泌尿道感染治疗主要市场趋势

  • 尿路感染治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 尿路感染治疗市场限制
    • 市场限制影响分析
  • 尿路感染治疗市场机会
  • 尿路感染治疗市场未来趋势

第 4 章：泌尿道感染治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：泌尿道感染治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：泌尿道感染治疗市场格局

  • 2023 年泌尿道感染治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：泌尿道感染治疗市场 - 依疾病分类

  • 概述
    • 按疾病分類的细分市场占有率分析
    • 复杂性泌尿道感染
    • 简单的泌尿道感染

第 8 章：泌尿道感染治疗市场 - 依药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 奎诺酮类
    • β内酰胺类
    • 大环内酯类
    • 氨基糖苷类
    • 其他的

第 9 章：泌尿道感染治疗市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 零售药局
    • 网路药局
    • 医院药房

第 10 章：泌尿道感染治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美尿路感染治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按疾病）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲泌尿道感染治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区尿路感染治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲尿路感染治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病）
    • 拉丁美洲市场规模与预测（按药物类别）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲泌尿道感染治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 泌尿道感染治疗产业

  • 竞争仪表板
  • 公司简介
    • AbbVie Inc.
    • Pfizer Inc.
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Roche Holding AG
    • Allergan plc
    • BDR Pharma
    • Bayer AG
    • Bristol-Myers Squibb
    • AstraZeneca plc
    • Novartis International AG
    • Sanofi SA
    • Eli Lilly and Company
    • Spero Therapeutics
    • Paratek Pharmaceuticals
    • Iterum Therapeutics
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2947

REPORT HIGHLIGHT

Urinary Tract Infection Treatment Market size was valued at USD 9,238.21 Million in 2023, expanding at a CAGR of 3.98% from 2024 to 2032.

Treatment for urinary tract infections (UTIs) usually consists of a mix of prescription drugs, dietary adjustments, and preventative measures. To avoid consequences like kidney infections or repeated infections, proper diagnosis and treatment are essential for UTIs.

Urinary Tract Infection Treatment Market- Market Dynamics

The growing prevalence of urinary infections and advanced diagnostic techniques are expected to propel market demand

The need for efficient treatment alternatives is fueled by the rising prevalence of Urinary Tract infections (UTIs), which are especially common in women, the elderly, and patients with chronic conditions is expected to boost the market growth. Being one of the most prevalent bacterial infections, UTIs require dependable and regular treatment alternatives. Higher diagnosis rates are the result of increased knowledge of UTI symptoms and the significance of prompt treatment. Improved diagnostic instruments and public health initiatives support early detection and treatment, which accelerates market expansion.

The accuracy and speed of diagnosing UTIs are enhanced by technological developments in diagnostic techniques, such as molecular diagnostics and fast urine testing. This improves treatment results and fuels the market for medical devices for diagnosis and treatment. Increasing healthcare spending makes it easier to access medical facilities and UTI treatments, especially in developing nations. The market for UTI treatments is growing because of these economic factors. Additionally, the market is positively impacted by government activities and healthcare organizations' support for better UTI management. These initiatives include funding for research and development, public health campaigns, and enhanced healthcare infrastructure.

Urinary Tract Infection Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.98% over the forecast period (2024-2032)

Based on Disease segmentation, the complicated UTIs segment was predicted to show maximum market share in the year 2023, owing to the growing prevalence of urinary disorders.

Based on Drug Class segmentation, the Quinolones segment was the leading Drug Class in 2023, due to high demand for kidney-related disease treatment.

Based on Distribution Channel segmentation, the hospital pharmacies segment was the leading Distribution Channel in 2023, owing to the high demand for treatment of kidney and diabetic disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to growing healthcare spending by companies.

Urinary Tract Infection Treatment Market- Segmentation Analysis:

The Global Urinary Tract Infection Treatment Market is segmented on the basis of Disease, Drug Class, Distribution Channel, and Region.

The market is divided into two categories based on Disease: complicated UTIs and uncomplicated UTIs. The complicated UTIs segment dominates the market. Advancement in disease treatment and the adoption of new devices are fueling the segment's growth.

The market is divided into five categories based on the Drug Class: quinolones, beta-lactams, macrolides, aminoglycosides, and others. The quinolones segment dominates the market. The growing demand from people seeking medical attention owing to increased knowledge regarding UTIs is contributing to market growth.

The market is divided into three categories based on Distribution channels: retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment dominates the market and is expected to maintain its high dominance during the forecast period. Online pharmacies is expected to grow at the fastest CAGR with the rising e-commerce sector which is accelerating the growth of the market.

Urinary Tract Infection Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is dominating the global market. The region has advanced healthcare infrastructure that supports easy access to diagnosis and treatment. North America has the largest market share due to high healthcare expenditure and the robust pharmaceutical industry. Asia Pacific is estimated to expand at the highest rate over the forecast period.

Urinary Tract Infection Treatment Market- Competitive Landscape:

The Urinary Tract Infection (UTI) treatment market is significantly competitive and comprises several key players involved in the development, manufacturing, and distribution of pharmaceuticals and therapies for UTI management. Companies are engaged in research to develop next-generation antibiotics and treatments aimed at multidrug-resistant infections. For example, GSK plc is involved in collaborative efforts to tackle antimicrobial resistance and has several compounds in clinical trials for bacterial infections.

Recent Developments:

In 2022, Spero Therapeutics Inc. offered an NDA to the US Food and Drug Administration (FDA) and got approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI).

In 2022, BDR Pharma, a leading generic pharmaceutical company in India, introduced biapenem to treat patients with intra-abdominal infections, and complex UTIs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET KEY PLAYERS

  • AbbVie Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Roche Holding AG
  • Allergan plc
  • BDR Pharma
  • Bayer AG
  • Bristol-Myers Squibb
  • AstraZeneca plc
  • Novartis International AG
  • Sanofi S.A.
  • Eli Lilly and Company
  • Spero Therapeutics
  • Paratek Pharmaceuticals
  • Iterum Therapeutics
  • Others

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019-2032

  • Complicated UTIs
  • Uncomplicated UTIs

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019-2032

  • Quinolones
  • Beta lactams
  • Macrolides
  • Aminoglycosides
  • Others

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

  • Retail pharmacies
  • Online pharmacies
  • Hospital pharmacies

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Urinary Tract Infection Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Urinary Tract Infection Treatment Market Snippet by Disease
    • 2.1.2. Urinary Tract Infection Treatment Market Snippet by Drug Class
    • 2.1.3. Urinary Tract Infection Treatment Market Snippet by Distribution Channel
    • 2.1.4. Urinary Tract Infection Treatment Market Snippet by Country
    • 2.1.5. Urinary Tract Infection Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Urinary Tract Infection Treatment Key Market Trends

  • 3.1. Urinary Tract Infection Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Urinary Tract Infection Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Urinary Tract Infection Treatment Market Opportunities
  • 3.4. Urinary Tract Infection Treatment Market Future Trends

4. Urinary Tract Infection Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Urinary Tract Infection Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Urinary Tract Infection Treatment Market Landscape

  • 6.1. Urinary Tract Infection Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Urinary Tract Infection Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2024 & 2032 (%)
    • 7.1.2. Complicated UTIs
    • 7.1.3. Uncomplicated UTIs

8. Urinary Tract Infection Treatment Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Quinolones
    • 8.1.3. Beta lactams
    • 8.1.4. Macrolides
    • 8.1.5. Aminoglycosides
    • 8.1.6. Others

9. Urinary Tract Infection Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Retail pharmacies
    • 9.1.3. Online pharmacies
    • 9.1.4. Hospital pharmacies

10. Urinary Tract Infection Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Urinary Tract Infection Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Urinary Tract Infection Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Urinary Tract Infection Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Urinary Tract Infection Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Urinary Tract Infection Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Urinary Tract Infection Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Johnson & Johnson
    • 11.2.4. GlaxoSmithKline plc
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. Roche Holding AG
    • 11.2.7. Allergan plc
    • 11.2.8. BDR Pharma
    • 11.2.9. Bayer AG
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. AstraZeneca plc
    • 11.2.12. Novartis International AG
    • 11.2.13. Sanofi S.A.
    • 11.2.14. Eli Lilly and Company
    • 11.2.15. Spero Therapeutics
    • 11.2.16. Paratek Pharmaceuticals
    • 11.2.17. Iterum Therapeutics
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Urinary Tract Infection Treatment Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Urinary Tract Infection Treatment Market, by Disease 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Urinary Tract Infection Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Urinary Tract Infection Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Urinary Tract Infection Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)